A novel myeloid cell in murine spleen defined through gene profiling by Hey, Ying Ying et al.
Bond University
Research Repository
A novel myeloid cell in murine spleen defined through gene profiling
Hey, Ying Ying; O'Neill, Terence; O'Neill, Helen C
Published in:
Journal of Cellular and Molecular Medicine
DOI:
10.1111/jcmm.14382
E-pub ahead of print: 18/06/2019
Document Version:
Publisher's PDF, also known as Version of record
Link to publication in Bond University research repository.
Recommended citation(APA):
Hey, Y. Y., O'Neill, T., & O'Neill, H. C. (2019). A novel myeloid cell in murine spleen defined through gene
profiling. Journal of Cellular and Molecular Medicine, [14382]. https://doi.org/10.1111/jcmm.14382
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 10 Aug 2019
J Cell Mol Med. 2019;00:1–16.	 	 	 | 	1wileyonlinelibrary.com/journal/jcmm
1  | INTRODUC TION
Myelopoiesis is a regulated process of cell development leading 
to multiple cell types which contribute to both innate and adap-
tive immunity. A common myeloid progenitor in adult bone mar-
row gives rise to monocytes/macrophages, dendritic cells (DC) and 
granulocytes including neutrophils, eosinophils, basophils and mast 
cells.1-3 The spleen contains multiple myeloid subsets. While DC sub-
sets are well characterized, the monocyte, macrophage and granulo-
cyte lineages are less well defined.
Conventional(c) DC represent the main DC subset in murine spleen 
and have been further classified as functionally distinct CD8+ and 
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Abstract
A novel myeloid antigen presenting cell can be generated through in vitro haemat-
opoiesis in long-term splenic stromal cocultures. The in vivo equivalent subset was 
recently identified as phenotypically and functionally distinct from the spleen sub-
sets of macrophages, conventional (c) dendritic cells (DC), resident monocytes, in-
flammatory monocytes and eosinophils. This novel subset which is myeloid on the 
basis of cell surface phenotype, but dendritic-like on the basis of cell surface marker 
expression and antigen presenting function, has been tentatively labelled “L-DC.” 
Transcriptome analysis has now been employed to determine the lineage relationship 
of this cell type with known splenic cDC and monocyte subsets. Principal compo-
nents analysis showed separation of “L-DC” and monocytes from cDC subsets in the 
second principal component. Hierarchical clustering then indicated a close lineage 
relationship between this novel subset, resident monocytes and inflammatory mono-
cytes. Resident monocytes were the most closely aligned, with no genes specifically 
expressed by the novel subset. This subset, however, showed upregulation of genes 
reflecting both dendritic and myeloid lineages, with strong upregulation of several 
genes, particularly CD300e. While resident monocytes were found to be depend-
ent on Toll-like receptor signalling for development and were reduced in number in 
Myd88-/- and Trif-/- mutant mice, both the novel subset and inflammatory monocytes 
were unaffected. Here, we describe a novel myeloid cell type closely aligned with 
resident monocytes in terms of lineage but distinct in terms of development and 
functional capacity.
K E Y W O R D S
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CD8− subsets.4 CD8+ cDC are distinct as CD11chiCD11b−CD8α+MHCII+ 
cells, while CD8− cDC have a CD11chiCD11bloCD8α−MHCII+ pheno-
type.5 These subsets differ in immune function, including cytokine 
production and ability to cross-present antigen.6 The plasmacytoid (p)
DC is another common splenic DC subset, existing as a plasmacytoid 
preDC in the steady-state.7 Under inflammatory conditions, mono-
cyte-derived (mo)-DC can develop when inflammatory stimuli recruit 
circulating classical or inflammatory monocytes from blood into spleen 
where they differentiate.8-10 Dendritic cells are located mainly within 
the white pulp region of spleen where immune responses against 
blood-borne antigens and pathogens are initiated, while myeloid cells 
are primarily located within the red pulp region.
Spleen contains several subsets of tissue-resident macrophages, 
namely marginal zone and marginal metaphyllic macrophages, red 
pulp macrophages and tingible body macrophages in the white pulp 
region.11 While the yolk sac origin of red pulp macrophages is under-
stood,12-14 their relationship with splenic monocytes resident mainly 
in the red pulp region is still unclear. To date, no distinct phenotypic 
markers are available which can be used to distinguish red pulp mac-
rophages from other myeloid subsets present in the red pulp. The 
distinction and lineage relationship between splenic monocytes and 
red pulp macrophages is not well understood.
Monocytes in blood and spleen are thought to derive from my-
eloid precursors in bone marrow.7 Two main subsets of circulating 
monocytes in blood are also present in spleen: the CX3CR1
loLy6Chi 
inflammatory or classical monocytes, and the CX3CR1
hiLy6C− res-
ident or non-classical monocytes.9 Phenotypic identity of the two 
main monocyte subsets in spleen was recently clarified in this lab 
through marker phenotype and functional analysis.15-17 That study 
also classified splenic macrophages as CD11blo cells, with distinct 
macrophage subsets identifiable through staining with specific sub-
set	markers	of	SIGNR1,	MOMA-1,	CD69	and	F4/80.17
Under inflammatory conditions, both classical or inflammatory 
monocytes and non-classical or resident monocytes are selectively 
mobilized from spleen to the site of inflammation. Here, classical 
monocytes clear damaged tissues, while non-classical monocytes 
promote wound healing.18 Inflammatory monocytes can also home 
to sites of infection where they differentiate to give mo-DC,19 while 
resident monocytes home to non-inflammatory sites where they 
are thought to differentiate to give macrophages in some tissues, eg 
liver and spleen.19 Deployment of a reservoir of splenic monocytes 
was hypothesized as a mechanism for faster initiation of an immune 
response. Information on the function of non-classical (resident) 
monocytes, and whether or not they differentiate to give macro-
phages within tissues, is still debatable. However, all tissue-resident 
macrophages are not derived from resident monocytes and evidence 
for a yolk sac or foetal origin for tissue resident macrophages is 
forthcoming for some tissues.14
All evidence points to a major role for spleen in myelopoiesis. 
Our own previous work has identified a novel CD11bhiCD11cloMHC-
II− cell type in spleen. This was investigated as an in vivo equivalent 
to the named “L-DC” subset of dendritic-like antigen presenting cells 
produced in long-term co-cultures of haematopoietic progenitors 
over splenic stromal lines. The original studies on “L-DC” produced in 
vitro described a dendritic-like cell type which was distinct in terms 
of its phenotype as a CD11bhiCDllcloMHC-II− cell antigen presenting 
cell, having very strong capacity to cross-present antigen and to acti-
vate CD8+ cytotoxic T cells.20-22 It was predicted that such a cell type 
located in spleen may play a unique role in the induction of CD8 T 
cell immunity to blood-borne antigens like pathogens and dead can-
cer cells (REF).21,22	Their	inability	to	activate	CD4+ T cells would be 
consistent with their location and function at the level of the spleen 
and	the	blood	stream	because	CD4+	T	cell	activation	and	cytokine	
production might be toxic.
In light of their unique functional capacity, studies were initiated 
to identify this specific cell type in spleen. The absence of specific 
markers made this process difficult. However, through a series of 
studies dissecting the myeloid cell populations in both murine and 
human spleen,15,23 this novel splenic subset has been identified and 
analysed in terms of function equivalent to the in vitro-derived cell 
type. The “L-DC” subset in mice has been shown to be phenotypi-
cally distinct from the four splenic macrophage subsets,17 and both 
phenotypically and functionally distinct from the two splenic mono-
cyte subsets.15,16 It was also clearly distinguished from the main 
splenic DC subsets.15-17,24 In terms of antigen presenting capacity, 
this novel subset is superior in capacity to cross-present antigen to 
CD8 T cells and to activate cytotoxic function, although incapable of 
activating	of	CD4	T	cells.16 These cells were shown by gene profiling 
to reflect a distinct cell type expressing genes common to both my-
eloid and dendritic lineages.16 This novel subset closely resembles 
dendritic-like cells produced in vitro in long-term cultures of spleen 
(LTC-DC) and similar cells produced in co-cultures of bone marrow 
progenitors over splenic stromal lines.20,25-27 For this reason alone, it 
has been referred to as “L-DC” in these studies.
Transcriptome analysis has been used here to analyse the rela-
tionship between this new subset and resident and inflammatory 
monocyte subsets in spleen, eosinophils and the CD8+ cDC and 
CD8− cDC subsets. These subsets were isolated in line with a re-
cently published subset identification method which redefined the 
resident monocyte subset in spleen, and also identified splenic 
eosinophils more fully.15 Gene profiling now clearly distinguishes 
this novel subset. While it is found to be closely related to resident 
and inflammatory monocytes, evidence presented here also distin-
guishes it as developmentally and functionally distinct.
2  | MATERIAL S AND METHODS
2.1 | Animals
Specific	 pathogen-free	 C57BL/6J,	 C57BL/6-MyD88−/− (MyD88−/−) 
and	 C57BL/6-TRIF−/− (TRIF−/−) mice were obtained from the 
John Curtin School of Medical Research (JCSMR, Australian 
National	 University	 (ANU)	 and	 used	 at	 4-6	 weeks	 of	 age.	
C57BL/6-MyD88−/−TRIF−/− (MyD88−/−TRIF−/−) mice were purchased 
from the Walter and Eliza Hall Institute (WEHI: Parkville, Victoria, 
Australia)	 and	 used	 at	 4-6	weeks	 of	 age.	 Animal	 experimentation	
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was conducted according to protocols approved by the Animal 
Experimentation Ethics Committee at the ANU. Mice were sacri-
ficed by cervical dislocation.
2.2 | Cell preparation
Following dissociation of spleen tissue through crushing, T and B 
lymphocytes were depleted through column separation performed 
with MACS® technology (Miltenyi Biotec: Auburn, California, USA). 
Cells were resuspended at 108 cells/mL in MACS labelling buffer 
(2 mmol/L EDTA/0.5% BSA in PBS) and incubated on ice for 25 min-
utes with antibody: 0.2 µg biotinylated anti-Thy1.2 antibody/108 
cells (T cells) and 0.25 µg biotinylated anti-CD19 antibody/108 cells 
(B	cells)	in	1	mL	for	30	minutes	at	4°C.	Cells	were	washed	by	centrif-
ugation, labelled by addition of 20 µL of anti-biotin microbeads/108 
cells (Miltenyi) with incubation for 25 minutes on ice, followed by 
washing and resuspension in 500 µL of MACS labelling buffer. 
Separation involved use of LS columns (Miltenyi) in a SuperMACS 
II Separation Unit (Miltenyi), followed by washing thrice with 3 mL 
of MACS buffer. Unbound cells collected as flow-through from the 
column were enriched for myeloid and dendritic cells.
2.3 | Antibody staining and flow cytometry
Procedures for staining cells with antibodies for flow cytometry have 
been described in detail in earlier studies.15 Anti-CD16/32 (FcBlock: 
5 µg/mL) (Biolegend, San Diego, CA, USA) was used to block non-spe-
cific antibody binding through Fc receptors. Fluorochrome- or biotin-
conjugated	antibodies	used	were	specific	for	CD11b,	(M1/70),	CD11c	
(N418),	 Ly6C	 (Al-21),	 Ly6G	 (1A8),	 CD8	 (53-6.7),	 CD43	 (1B11)	 and	
Siglec-F	 (E50-2440)	 (Biolegend).	Propidium	iodide	staining	 (PI;	1	µg/
mL) prior to flow cytometry was used to identify and gate live (PI−) 
cells. Flow cytometric analysis of labelled subsets was performed on a 
BD LSRII flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). 
FACSDiva software (Becton Dickinson) was used to acquire data. FloJo 
software (Tree Star, Ashland, OR, USA) was used for data analysis.
2.4 | Transcriptome analysis
Cell sorting of dendritic and myeloid subsets in spleen was per-
formed as described previously15 with a FACSAria cell sorter (Becton 
Dickinson). RNA was extracted with an RNeasy mini kit (Qiagen, 
Clifton Hill, VIC, Australia) and used to prepare labelled cDNA for 
hybridization to genechips. Label preparation and hybridization was 
performed by Dr Kaiman Peng (Biomolecular Resource Facility, ANU, 
Canberra, ACT, Australia). The procedure followed the protocols 
for Applause WT-Amp ST and WT-Amp Plus ST RNA Amplification 
Systems posted on the website of NuGEN Technologies (San Carlos, 
CA, USA) (http://www.nugen inc.com/nugen/ index.cfm/produ cts/
apl/appla use-rna-ampli ficat ion-syste ms/). Amplification of cDNA 
involved the SPIA amplification kit (NuGEN Technologies). The 
cDNA samples were fragmented and labelled according to the FL-
OvationTM cDNA Biotin Module V2 protocol (NuGEN Technologies), 
followed by hybridization to Mouse Gene 1.0 ST genechips 
(Affymetrix, Santa Clara, CA, USA). These were washed and stained 
with the Affymetrix fluidics station prior to scanning and analysis 
with an Affymetrix GeneArray® Scanner. Duplicate arrays were pre-
pared for each subset.
2.5 | Microarray data analysis
Initial analysis was performed by Dr Stephen Ohms (Biomolecular 
Resource Facility, ANU). Scanned images of labelled genechips pre-
pared in duplicate experiments were analysed with Partek to give 
average signal values and P values. Data files containing probeset 
numbers, gene descriptions, signal values and P-values were prepared 
in text file format and subsequently exported into Microsoft Excel 
for principal components analysis. ANOVA was used for selection 
of genes up- or down-regulated in pairwise comparison. Data mining 
was also used to assess the expression of genes linked to known func-
tions in development or associated with distinct cell lineages. In addi-
tion, agglomerative hierarchical clustering (with the Lance–Williams 
dissimilarity formula)28 and heatmap analysis were performed with R 
project (http://www.r-proje ct.org/). Results of hierarchical clustering 
analysis are presented as dendrograms on heatmaps.
2.6 | Statistical analysis
Where indicated, data has been obtained from multiple animals, data 
are presented as mean ± SE for sample size (n). The Student’s t test 
has been used to determine significance (P	≤	0.05).
3  | RESULTS
3.1 | Transcriptome analysis of splenic dendritic and 
myeloid subsets
The clearly defined populations of resident monocytes, inflamma-
tory monocytes, eosinophils, CD8+ cDC and CD8− cDC were sorted 
from	spleens	of	C57BL/6J	mice	according	to	the	staining	procedure	
developed previously (Table 1).15,16 This procedure initially gated out 
splenic macrophages on the basis of their CD11bloCD11c− phenotype 
TA B L E  1   Phenotype of myeloid and dendritic cell subsets under study
L‐DC Resident monocytes Inflammatory monocytes Eosinophils CD8+ cDC CD8− cDC
CD11cloCD11bhi CD11cloCD11bhi CD11c−CD11bhi CD11c−CD11bhi CD11chiCD11b− CD11chiCD11b+
Ly6C−Ly6G− Ly6C+Ly6G− Ly6ChiLy6G− Ly6C+Ly6G− Ly6C−Ly6G− Ly6C−Ly6G−
CD43+SiglecF− CD43+SiglecF− CD43+SiglecF− CD43+SiglecF+ CD8+ CD8−
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as determined previously,17 and then identified monocytes and den-
dritic cells amongst the CD11bhi population.15,17 The phenotype of 
subsets under study here is summarized in Table 1. “L-DC” are distin-
guished as a CD11bhiCD11cloMHCII−Ly6C−Ly6G− subset also shown 
to be CX3CR1loCD43loSiglec-F−. They are distinct from eosinophils 
on the basis of CD11clo expression and lack of Ly6C and Siglec-F 
expression. As CX3CR1
loLy6C−CD115− cells, they are distinct from 
CX3CR1
hiLy6CloCD115+ resident monocytes. “L-DC” are also dis-
tinct from CD11c−Ly6Chi inflammatory monocytes. They are clearly 
distinct from cDC in that they lack MHCII expression and because 
they	 express	 CD43	 and	 CX3CR1. High purity RNA was extracted 
from cells, converted to cDNA, biotin-labelled and then hybridized 
to Murine Gene ST1.0 genechips (Affymetrix) for analysis of relative 
gene expression.
The pairwise relationship between subsets was demonstrated 
with bivariate plots displaying gene expression in terms of signal 
value for a total of 35 556 genes (Figure 1A). “L-DC” and resident 
monocytes showed the least variance with very few differentially 
expressed genes evident as outliers (Figure 1A). A comparison of 
“L-DC” and inflammatory monocytes showed more differentially 
F I G U R E  1   Variability in gene expression amongst dendritic and myeloid subsets. Transcriptome analysis was performed on subsets of 
cells sorted from murine spleen. RNA was extracted and labelled for hybridization to Murine Gene ST1.0 genechips (Affymetrix). Following 
scanning to collect signal values from samples prepared in duplicate experiments, data were analysed using Partek and ANOVA by pairwise 
comparison. A, Mean signal values were calculated and plotted for a total of 35 556 genes in pairwise subset comparisons. The darker blue 
inner polygon contains 50% of data points, while the pale blue outer polygon contains all other data points which are not outliers (shown 
in red outside the polygon). The bivariate median is shown by the red asterisk at the centre of the polygon. B, Principle component analysis 
was used to determine variability in gene expression for each subset. Three principle components are shown for each subset prepared for 
analysis in duplicate experiments. C, Hierarchical clustering was used to analyse the relationship between subsets on the basis of average 
gene expression. The dendrogram displays distance between subsets based on clustering of 8508 genes selected for analysis on the basis of 
mean	signal	value	≥100	for	any	one	subset
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expressed genes. The “L-DC” and cDC subsets showed more vari-
ation with many differentially expressed genes evident as outliers. 
The resident and inflammatory monocyte subsets showed very few 
differentially expressed genes, indicating a close relationship. The 
CD8+ cDC and CD8− cDC subsets gave a tight bivariate plot with a 
high number of differentially expressed genes. Eosinophils showed 
the greatest difference in gene expression in comparison with all 
other subsets (Figure 1A).
Differences in overall gene expression between the subsets 
were also evident through principal component analysis (PCA). This 
showed close grouping of resident monocytes, inflammatory mono-
cytes, “L-DC” and cDC subsets in the first principal component, but 
separation of “L-DC” and monocyte subsets from cDC subsets in the 
second principal component (Figure 1B). In addition, CD8+ cDC were 
clearly differentiated from CD8− cDC in the second principal com-
ponent. Lastly, eosinophils were distinct from all other subsets on 
the basis of the first and second principal components. This analysis 
indicated similarity between “L-DC” and monocytes and clearly dif-
ferentiated “L-DC” from eosinophils and cDC subsets.
Hierarchical clustering was then used to map the relationship 
between subsets based on gene expression (Figure 1C). Average sig-
nal values from duplicate samples were used for clustering. Genes 
were included which showed expression in at least one subset (signal 
value	≥100),	giving	a	 sample	set	of	8508	genes.	The	analysis	 indi-
cated a close relationship between “L-DC” and resident monocytes 
and then between these two subsets and inflammatory monocytes. 
CD8+ cDC and CD8− cDC were closely related and distinct from the 
cluster of “L-DC,” resident monocytes and inflammatory monocytes. 
As predicted from PCA analysis, eosinophils were quite distinct as a 
subset and lineage.
3.2 | Investigation of gene expression specific 
to subsets
The lineage origin of the different subsets was investigated by data 
mining and comparing the expression level of known genes to func-
tional categories of “DC and APC,” “Chemokines,” “Cell surface mark-
ers” and “Inflammatory cytokines and receptors.” Signal values were 
collected	for	sets	of	84	genes	utilized	by	SABiosciences	(Frederick,	
MD USA) in their PCR arrays. Data are shown as heatmaps with den-
drograms reflecting hierarchical clustering. Gene expression is only 
shown for genes expressed by at least one subset having a signal 
value	 ≥100	 (Figure	 2A-D).	 The	CD8+ cDC and CD8− cDC subsets 
showed greatest similarity in gene expression and this was reflected 
in three of four analyses. These two subsets were reflective of the 
DC lineage by common high expression of genes encoding cell sur-
face markers including Cd40, Cd74, Cd80, Cd83, Dpp4 and St6gal1 
and genes encoding DC and APC markers including Flt3, H2‐Dma and 
Cdc42 (Figure 2A and 2).29-32 Genes upregulated by CD8+ cDC in-
cluded Cd8α, Cd24, Cd86 and Cd36, all of which encode known mark-
ers of this subset5,32-34 CD8− cDC showed specific high expression of 
Cd7, Cd22, Cd72, Klrd1, Cd209a and Tlr1 which are also known mark-
ers of CD8− cDC (Figure 2A and 2).31,32 In terms of genes encoding 
chemokines, inflammatory factors and related genes, the two cDC 
subsets showed common expression of Ccr7, Ccl5, IL‐1b, Itgb2, IL2rg 
and IL‐10ra (Figure 2C and 2).35,36 CD8+ cDC were uniquely marked 
by expression of Xcr1 as reported previously,37-39 as well as expres-
sion of Cxcl9.40 CD8− cDC also specifically expressed Ccl3 (Figure 2C 
and 2). These data, and their concordance with descriptions of cDC 
gene expression in the literature, confirm the efficiency of the cell 
sorting procedure and gene profiling methodology developed here.
Resident and inflammatory monocytes shared similar gene 
expression profiles for all functional categories with exceptions 
amongst chemokines and their receptors and cell surface mark-
ers (Figure 2A-D). Both monocyte subsets expressed Csf1r which 
encodes the receptor for macrophage colony stimulating factor 
(M-CSF). In addition, they also expressed Ccr2 which encodes an 
essential receptor for monocyte migration.9,41 Common expres-
sion of Cxcr3 identifies them as monocyte/macrophage as opposed 
to dendritic lineage cells.42 They also commonly expressed Itgam, 
Ccl6, Itgb2, IL1b, Ccl3, IL2rg, Cd244, Kldr1, Lyn, CD44, Cd36, Ptprc and 
Cdc42. Resident monocytes specifically expressed Ccl5 and Cd209a 
which encodes DC-SIGN a binding protein for pathogens commonly 
expressed by DC.43 Inflammatory monocytes specifically expressed 
Ccl9. Eosinophils were distinct from all other myeloid and DC subsets 
on the basis of their gene expression profile (Figure 2A-D), express-
ing high levels of Ccl6, Cd24a, Ptprc and Cdc42. Weaker expression of 
Krt8, Ccl19 and Cxcl13 confirmed their phenotype as reported pre-
viously.44,45 As eosinophils are shown here to be very distinct from 
cDC and other myeloid subsets, they have been disregarded from 
further analysis directed at lineage determination for “L-DC.”
The “L-DC” subset showed gene expression more closely linked 
with resident monocytes than with any other subset across the 
four functional categories studied. This is shown both in bivariate 
analysis, PCA and clustering (Figure 1), and by dendrograms above 
all heatmaps (Figure 2). In addition, inflammatory monocytes were 
closely clustered with both resident monocytes and “L-DC.” Genes 
commonly expressed at high levels across “L-DC” and both monocyte 
subsets included Itgam, Cx3cr1, Csf1r, Itgb2, Ccl6, IL1b, Ccl3, Cdc42, 
Ptprc, CD244 and IL2rg. Itgam encodes CD11b, a common marker of 
myeloid cells which mediates the inflammatory response by regulat-
ing adhesion and migration of cells to sites of infection.46,47 Cx3cr1 
encodes a marker common to cells of the myeloid lineage.48-50
Recently, Gautiar et al (2012) analysed gene expression in differ-
ent tissue macrophage subsets. That study defined a core signature 
of 39 genes defining tissue macrophages.51 In that study, splenic red 
pulp	macrophages	were	sorted	as	F4/80hiB220− with the absence of 
high expression of MHC-II and CD11c.51 This delineation would now 
be considered too broad incorporating some DC and mo-DC which 
express	F4/80	and	Cd11c.	Expression	of	those	39	genes	was	deter-
mined for the subsets isolated here by data mining, but none of the 
subsets expressed all 39 genes, and most expressed very few (Figure 
S1). This suggests that none of the subsets analysed here reflect red 
pulp macrophages. Further investigation of “L-DC” has shown it to 
be readily distinguishable from red pulp macrophages through phe-
notype15,17 and lack of expression markers like ITGA9 and VCAM-1 
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and genes like SpiC and Mertk, previously associated with red pulp 
macrophages (data not shown).51
3.3 | Genes upregulated in the novel subset
Data sets were extracted to identify genes upregulated at least 
threefold in either “L-DC” or the two monocyte subsets. “L-DC” and 
inflammatory monocytes were found to be the most distinct subsets, 
while “L-DC” and resident monocytes were the most closely related 
(Figure 3A). The data also predict a close relationship between resi-
dent monocytes and inflammatory monocytes, consistent with PCA 
and clustering evidence (Figure 1). Only four genes were found to be 
uniquely up-regulated in one of the three subsets. Upregulation of 
Fn1, F13a1 and Mmp8 identified inflammatory monocytes, and up-
regulation of Cd300e identified “L-DC” (Figure 3B). F13a1 encodes 
an alternate activation marker for macrophages,52,53 Fn1 encodes 
fibronectin1 (FN1), involved in cell adhesion, migration and growth 
and Mmp8 encodes matrix metalloproteinase-8 involved in the 
breakdown of extracellular matrix. FN1, F13A1 and MMP8, known 
to be specifically upregulated in inflammatory monocytes over resi-
dent monocytes.54
“L-DC” were found to be distinct from the two monocyte 
subsets through at least threefold upregulation of Cd300e which 
is also commonly expressed by all subsets. CD300E is a type I 
F I G U R E  2   Pathway-specific gene expression in dendritic and myeloid subsets. Data mining was applied to Affymetrix data sets collected 
from “L-DC,” cDC and myeloid subsets prepared in duplicate experiments. For each subset, log2 average signal values were plotted as a 
heat map. The line chart (blue) overlaid on heat maps indicates log2 signal intensity changes about the mean (dashed blue line). Genes were 
clustered by level of expression as shown by row dendrograms. In addition, dendritic and myeloid subsets were clustered on the basis of 
gene expression as shown by column dendrograms. Data mining involved sets of genes utilized by SABioscience for their PCR arrays. These 
reflect: (A) Cell surface markers, (B) DC and APC markers, (C) Chemokines and (D) Inflammatory cytokines and receptors
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transmembrane protein with a short cytoplasmic tail and a charged 
transmembrane residue which interacts with DAP12.55 It was 
previously shown to be expressed by macrophages/monocytes, 
mo-DC, and at lower levels in in vitro-derived macrophages and 
DC.55 Upon binding, CD300E induces activation signals calcium 
mobilization and release of reactive oxygen species by mono-
cytes.56,57 In addition, CD300E binding also induces cytokine 
release by monocytes and promotes survival of monocytes and 
mo-DC.56,57 DC activated via CD300E have stronger capacity to 
stimulate T cells.57 CD300E upregulation is consistent with the su-
perior antigen presenting capacity of “L-DC” over the other mono-
cyte subsets.16,17 Other genes which were upregulated at 2.5-fold 
included Cd300ld, Serpinb6a and Dnahc12 (Figure 3C). CD300LD 
belongs to the same family as CD300E and participates in signal 
transduction and production of pro-inflammatory cytokines.58,59 
Serpinb6a encodes a protein essential for protection against cyto-
toxic granules,60 while Dnahc12 encodes a protein that forms part 
of dynein.61	Genes	upregulated	≥2-fold	in	“L-DC”	over	other	sub-
sets were mainly proteases, adhesion proteins and transmembrane 
proteins. Upregulation of Fcgr4 is of interest because CD300E has 
been shown to physically interact with FcRγ.62
3.4 | Identification of genes which 
distinguish the novel subset from resident monocytes
Both PCA and gene expression analyses revealed a close develop-
mental relationship between resident monocytes and “L-DC” which 
differ	from	resident	monocytes	through	low	expression	of	CD43	and	
absence of Ly6C expression (Table 1). To further investigate this re-
lationship, genes specifically upregulated in either “L-DC” or resident 
monocytes	were	identified	(Figure	4).	Cd300e and Cd9 were shown 
to be upregulated in “L-DC” over resident monocytes, along with 
Dnahc12, Tgm2, Pecam1, Fabp4, Rab11, Serpinb6a, Abhd2 and Sash3 
(Figure	4A).	Both	CD300E	and	CD9	regulate	the	ability	of	DC	and	
monocyte/macrophages to activate T cells.56,57,63 In addition, CD9 
also modulates cell adhesion and migration64 and acts as a potent 
co-stimulatory molecule for T cells.63 DNAHC12 belongs to the 
dynein family, comprising proteins that convert energy in ATP into 
movement,61	while	FABP4	 is	 involved	 in	T	 cell	 priming	via	 regula-
tion of IFN-γ production by CD8+ T cells.61,65,66 TGM2 is involved 
in multiple processes including apoptosis and signal transduction.67 
RAB11B has been found to participate in both endocytic and exo-
cytic pathways involving Fc receptors to transport intracellular an-
tigens.68,69 SERPINB6A is essential for protecting CD8+ T cytotoxic 
lymphocytes against the action of their own cytotoxic granules.60 
SASH3, also known as SLY1, participates in the regulation of mar-
ginal zone B cell development via the Notch signalling pathway.70 All 
of these genes reflect the function of APC and are consistent with 
the defined functional role of “L-DC” in CD8+ T cell activation and 
cytotoxic function.16,17
Consistent with the reports in the literature, resident mono-
cytes expressed Ly6c1, Ly6c2 and Ccr2	 (Figure	4A).9,41 Expression 
of Ly6C1/2 reflects the sorting strategy used here, whereby resi-
dent monocytes were separated from “L-DC” (Table 1). In addition, 
resident monocytes also showed upregulation of several genes 
known to be expressed by myeloid cells including Chi3l3, Ifi205, 
F I G U R E  3   Differential gene expression between “L-DC” and 
monocyte subsets. ANOVA was used to make pairwise comparisons 
of average gene expression (n = 2) between different subsets and 
to calculate relative fold changes. A, Venn diagram shows numbers 
of	genes	upregulated	≥3-fold	in	one	of	two	subsets	assessed	
in pairwise comparison. Infl mono: Inflammatory monocytes; 
Resi mono: Resident monocytes; and “L-DC.” B, Genes uniquely 
expressed by each of the three subsets. C, Genes upregulated in 
‘L-DC’ and no other dendritic or myeloid subset in spleen were 
selected	on	the	basis	of	mean	signal	value	in	“L-DC”	≥150,	with	fold	
change	between	“L-DC”	and	the	lowest	expressing	subset	≥2-fold,	
≥2.5-fold	and	≥3-fold	as	shown
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Msr1, Gm11428 and Cd209a	 (Figure	 4A).54,71-73 Chi3l3 is upregu-
lated	 ~270-fold	 by	 resident	monocytes	 over	 “L-DC.”	 CHI313	 is	 a	
marker of alternatively activated M2 macrophages involved in 
wound healing and tissue repair.74 Expression of Ifi205 regulates 
the inflammasome adapter protein ASC.75-77 Macrophage scav-
enger receptor (MSR1) is involved in the endocytosis of double-
stranded RNA, transportation to endosomes and interaction with 
TLR3 for triggering IFN responses.78,79 As with MSR1 and IFI205, 
CD209a is expressed by both macrophages and DC.80,81 CD209a 
binds mannose-type carbohydrates found on viruses, bacteria and 
fungi, and induces phagocytosis of pathogens by macrophages.82 
Gm11428 encodes AMWAP which is expressed by tissue macro-
phages, microglia and retinal cells and regulates proinflammatory 
microglia and macrophage activation.83 This phenotype distin-
guishes resident monocytes from the novel APC subset in that it 
reflects activated monocytes with wound-healing capacity perhaps 
related to M2 macrophages.
As very few genes were identified as upregulated by “L-DC” over 
resident monocytes, genes specifically expressed by “L-DC” or resi-
dent monocytes were sought. Genes were selected according to the 
criteria	of	signal	value	≥125	in	one	subset	and	≤50	in	the	other.	This	
gave a subset of seven genes specific to resident monocytes, but 
none	for	“L-DC”	(Figure	4B).	Amongst	genes	specifically	expressed	
by resident monocytes, Ngp, S100a8 and S100a9 encode monocyte 
and macrophage markers.84,85 NGP regulates monocyte functions 
of activation and recruitment into sites of infection.86 Both S100A8 
and	S100A9	have	been	described	as	activators	of	endogenous	TLR4,	
so promoting proinflammatory responses.84,85 LCN2 is expressed by 
neutrophils and limits bacterial growth via sequestration of bacterial 
siderophores containing iron.87 Both Fn1 and F13a1 are upregulated 
in	inflammatory	monocytes	over	resident	monocytes	(Figure	4B),	but	
resident monocytes have higher expression of these markers over 
“L-DC.” Gene expression analysis, therefore, enabled further distinc-
tion between resident monocytes and “L-DC.” Overall, “L-DC” show 
upregulation of many genes with functional roles in antigen pro-
cessing and presentation to T cells, while resident monocytes show 
upregulation of genes previously described in relation to monocyte 
and macrophage function. This evidence supports previous studies 
showing distinction in terms of marker expression, morphology and 
capacity to activate T cells.
F I G U R E  4   Genes upregulated or specifically expressed between “L-DC” and resident monocytes. ANOVA was used to make pairwise 
comparisons of average gene expression (n = 2) between subsets and to calculate relative fold changes. A, Genes upregulated in either 
“L-DC”	or	resident	monocytes	were	selected	as	those	for	which	the	signal	value	in	one	subset	was	≥50,	and	the	signal	value	in	the	second	
subset	was	≥125.	Data	shown	reflect	genes	with	≥2.5-fold	difference	in	signal	value.	B,	Genes	specifically	expressed	in	either	“L-DC”	or	
resident	monocytes	were	selected	on	the	basis	of	the	mean	signal	value	in	one	subset	≤50,	and	mean	signal	value	in	the	second	subset	≥125.	
No genes were found to be specifically expressed by “L-DC”
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3.5 | Identification of markers which distinguish 
resident and inflammatory monocyte subsets
Both resident (non-classical) monocytes and inflammatory (classical) 
monocytes are shown here to be closely related. Previously, blood-
derived inflammatory monocytes were described as precursors of 
resident monocytes,88,89 although that relationship is still unclear. 
Genes upregulated in one or other subset were therefore identified 
to further distinguish these two spleen monocyte subsets. In line 
with earlier gene expression profiles of murine blood monocytes,54 
resident monocytes from spleen upregulated genes encoding known 
markers such as Ccl5, Itgax, Cd300e, Dusp16, Cd36, H2‐Ab1 and Fabp4 
(Figure 5). Upregulation of Itgax (CD11c) by resident monocytes is 
consistent with the staining and gating strategy used here (Table 1). 
Upregulation of H2‐Ab1 and H2‐Aa by resident monocytes could in-
dicate potential to express MHCII and act as APC. Dusp16 is also 
upregulated and encodes a dual-specificity phosphatase that can 
regulate mitogen-activated protein kinase for signal transduction 
and gene transcription which selectively regulates cytokine produc-
tion by myeloid cells.90,91 Resident monocytes also show upregula-
tion of Ccl5 which encodes a chemokine involved in recruitment of 
leukocytes to sites of inflammation and promotes recruitment and 
survival of human macrophages.92 Inflammatory monocytes were 
found to upregulate several genes involved in inflammatory mono-
cyte function including Mmp8, F13a1 and Fn1 described previously, 
as well as Vcan, Cd14, Capg, Ms4a8a and Cxcl10 (Figure 5). Cd14 en-
codes a marker on human inflammatory monocytes which acts as a 
co-receptor	 for	TLR4	signalling.19,93 Capg encodes a protein which 
participates in control of actin-based motility in macrophages,94,95 
Ms4a8a encodes a tetraspanin as a marker of activated M2 mac-
rophages,96 and Cxcl10 encodes a chemokine produced mainly by 
neutrophils and inflammatory monocytes.97
3.6 | Toll‐like signalling during development 
distinguishes “L‐DC” and resident monocytes
Previously we showed that “L-DC” can develop in vitro from hemat-
opoietic stem cells (HSC) overlaid above splenic stroma.27 During 
inflammation, the binding of pathogen molecules to Toll-like recep-
tors (TLR) on HSC can trigger differentiation.98,99 The question of 
whether inflammatory signalling is required for the development 
of “L-DC” and other splenic dendritic and monocyte subsets in vivo 
was therefore addressed. TLR signalling involves the two adaptor 
proteins MYD88 and TRIF.100,101 MYD88 is required for all TLR sig-
nalling except TLR3,100,101 which uses TRIF for signal transduction 
and is involved in recognition of double-stranded RNA associated 
with viral infection.102	 TLR4	which	 binds	 lipopolysaccharide	 (LPS)	
uses both MYD88 and TRIF in association with Toll-interleukin 1 
receptor domain-containing adapter protein (TIRAP) or Trif-related 
adaptor molecule (TRAM), respectively.100,101 It has also been shown 
that dual signalling through MYD88 and TRIF are critical for maximal 
TLR4-mediated	maturation	of	DC.103
Analysis of “L-DC” development in MyD88−/− and Trif−/− mice, 
therefore, represents a complete test of whether inflammatory sig-
nals are essential for the development of “L-DC” from HSC. The per-
centage of “L-DC” and all splenic DC and myeloid subsets amongst 
F I G U R E  5   Genes upregulated in either 
resident monocytes or inflammatory 
monocytes. ANOVA was used to make 
pairwise comparisons between average 
gene expression (n = 2) in inflammatory 
and resident monocytes. Genes were 
selected	which	showed	≥4-fold	change	
in mean signal value in either resident 
monocytes (Resi mono) or inflammatory 
monocytes (Infl mono), where mean signal 
value	in	both	subsets	was	≥50
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the total dendritic and myeloid subset in spleen was, therefore, 
measured in MyD88−/−, Trif−/− and MyD88−/−/Trif−/− mice compared 
with wild-type control mice. In MyD88−/− mice, a significant 2.5-fold 
increase in the percentage of CD8− cDC was seen compared with 
wild-type mice (Figure 6A). Eosinophils showed a significant but 
small decrease. The populations of inflammatory monocytes, resi-
dent monocytes, “L-DC” and neutrophils in MyD88−/− mice were not 
significantly different from the wild-type mice. In Trif−/− mice, a sig-
nificant reduction in percentage of both CD8+ cDC and CD8− cDC 
was observed in Trif−/− mice compared with wild-type mice and is 
associated with TLR3 signalling (Figure 6B). Amongst the myeloid 
subsets, only resident monocytes showed a significant decrease 
compared with wild-type mice, while neutrophils demonstrated a 
significant increase. These data reveal dependency for TLR3 signal-
ing in development of cDC and resident monocytes, but not for “L-
DC” or inflammatory monocytes. The increase in neutrophil number 
could reflect the higher infection status of these mutant mice, or 
a compensatory effect. In MyD88−/−/Trif−/− double knockout mice 
which lack all TLR signalling, CD8− cDC showed a significant reduc-
tion in number, while there was no change in CD8+ cDC (Figure 6C). 
However, resident monocytes and eosinophils showed a significant 
reduction, while inflammatory monocytes and “L-DC” were unaf-
fected (Figure 6C). As with Trif−/− mice, neutrophils showed a signifi-
cant increase in percentage in MyD88−/−/Trif−/− over wild-type mice, 
which could reflect the infection or inflammatory status of these 
mice.
From combined studies on the three mutants, it was concluded 
that TLR signalling is important in the development of CD8− cDC, 
CD8+ cDC, eosinophils and resident monocytes. However, the de-
velopment of “L-DC” and inflammatory monocytes occurred inde-
pendently of TLR signalling, such that the latter two subsets develop 
in steady-state spleen. It is important to note that our protocol for 
delineation of the CD8− cDC subset could also capture inflamma-
tory or mo-DC whose development would be lost in mutant mice. As 
“L-DC” development occurs independently of inflammatory signals, 
these results serve to distinguish “L-DC” as a distinct subset from 
resident monocytes, and to definitively distinguish resident mono-
cytes from inflammatory monocytes.
4  | DISCUSSION
This study has made a number of contributions towards better un-
derstanding dendritic and myeloid subsets present in murine spleen. 
In particular, a novel subset equivalent to the in vitro generated “L-
DC” cell type has been characterized in terms of gene expression 
and shown to be distinct from other known DC subsets and monoc-
tyes. Full and complete analysis of splenic subsets initially required 
that splenic macrophages were first gated out, and that the mono-
cyte subsets were redefined.15-17 Inflammatory monocytes are now 
clearly distinguishable as a separate lineage from resident mono-
cytes, and are also distinct from the novel subset of interest. The 
resident monocyte subset defined in spleen was previously shown 
to be phenotypically distinct from resident monocytes previously 
defined in murine blood.15 Spleen resident monocytes are now 
shown to be closely related to a novel APC subset described here as 
“L-DC,” such that the two subsets may be derived from a common 
progenitor or lineage.104
The possibility that “L-DC” reflect a macrophage subset was 
considered but refuted previously.17 It will be necessary in future 
to better define macrophages amongst dissociated spleen cells 
on the basis of phenotype because most studies have used immu-
nocytochemical section staining to distinguish these cells. Using 
flow cytometry, splenic macrophages were here identified as 
CD11bloCD11c−Ly6C−/+Ly6G− cells through a series of staining and 
back-gating strategies. Further staining of this subset for markers re-
flecting specific macrophage types then confirmed that “L-DC” were 
distinct cells and not macrophages. “L-DC” did not express MOMA-1, 
a marker of marginal metaphyllic macrophages, nor SIGNR1, a 
marker of marginal zone macrophages.17	 “L-DC”	do	express	F4/80	
which has been described as expressed by red pulp macrophages and 
other dendritic and monocyte subsets in spleen. “L-DC” do not ex-
press CD68 as do red pulp macrophages and all other macrophages 
in spleen. “L-DC” are also distinct from neutrophils, eosinophils and 
inflammatory monocytes in terms of phenotype, morphology and 
gene expression,15 and can be delineated from neutrophils through 
lack	 of	 Ly6G	 and	 7/4	 expression.105,106 “L-DC” can be also distin-
guished from eosinophils by lack of Siglec-F expression,107,108 and 
from inflammatory monocytes through the expression of CD11c and 
absence of Ly6C expression (Table 1).
Ly6Chi inflammatory monocytes can give rise to mo-DC-like 
TNFα and iNOS-producing DC (Tip-DC) in murine tissues during 
inflammation. Tip-DC have also been described as classically acti-
vated M1 macrophages.109-111 It is notable that “L-DC” development 
occurs independently of inflammatory signals essential for genera-
tion of Tip-DC (Figure 6), and the “L-DC” phenotype is distinct from 
that of Tip-DC through lack of Ly6C and MHCII expression (Table 1). 
These findings clearly distinguish “L-DC” from mo-DC which develop 
in response to inflammation.
Based on gene expression data obtained here and phenotypic 
and functional data obtained previously,15-17,112 “L-DC” can be distin-
guished as a unique myeloid subset in spleen. They are more closely 
F I G U R E  6   “L-DC”	development	occurs	independently	of	Toll-like	receptor	signalling.	Splenocytes	were	harvested	from	C57BL/6J	mutant	
and	C57BL/6J	(wild	type)	mice.	Cells	were	stained	with	antibodies	to	delineate	subsets	as	described	in	Table	1.	Gates	were	set	based	on	
fluorescence minus one controls, to estimate % cells amongst the total myeloid and dendritic subset (CD11b+ and/or CD11c+) cells. Individual 
mice	were	analysed	(n	=	4	or	5).	A	bar	is	used	to	show	mean	values.	Wild	type	mice	(Open	circles)	were	compared	with	mutants	(filled	circles)	
(A) MyD88−/− (MyD88 KO) (B) Trif−/−	(TRIF	KO)	and	(C)	C57BL/6J	MyD88−/−TRIF−/− (MyD88/Trif KO). Red boxes indicate significant change in 
subset representation relative to wild-type mice using Student’s t test (P	≤	0.05)
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related to monocytes than to cDC, although the reason for this could 
relate to progenitor origin rather than function as an APC. Indeed, 
their function as APC is distinct from cDC subsets in that they ac-
tivate only CD8+	T	cells	and	not	CD4+ T cells, and appear to have 
capacity to cross-present antigen.16,17 The resident (non-classical) 
monocyte population in spleen quite distinct from the inflammatory 
(classical) monocyte subset, despite evidence for a common myeloid 
phenotype. Both CD8+ cDC and CD8− cDC were closely linked in 
terms of gene profile, and quite distinct from monocytes and the 
“L-DC” subset. Lastly, the gene profile of eosinophils was quite dis-
tinct from other subsets isolated, suggesting a distinct lineage origin, 
consistent with evidence that the eosinophil develops from a granu-
locyte/macrophage progenitor instead of the macrophage/dendritic 
progenitor.113-115
Gene profiling studies were conducted with a view to identifi-
cation of distinguishing markers for “L-DC” for better classification 
of this subset. However, markers were not found, and “L-DC” were 
shown to be closely related to resident monocytes differing only 
through upregulation of markers related to T cell activation capac-
ity, namely CD300E, CD300LD, SERPINb6a and CD9. SERPINb6a 
is widely expressed, and CD300E and CD300LD have expression 
aligned with DC subsets,59 non-classical monocytes and macro-
phages.62 While no specific genes were found to distinguish “L-DC” 
from resident monocytes, a number of specifically expressed genes 
did distinguish resident monocytes from “L-DC.” These genes re-
flect myeloid cells rather than DC including Ly6C, S100A8 and 
CD209. Although this expression pattern could be consistent with 
mo-DC,116 no evidence was found for upregulated CD206, or for 
production of TNF and iNOS, which are delineating markers of 
mo-DC.116,117
The possibility that “L-DC” reflect mo-DC was considered, and 
refuted on several accounts. Firstly, “L-DC” do not express mark-
ers identified for mo-DC including SIRPA, S100A8, CD206 and 
CD209a.116 Secondly, “L-DC” development both in vivo15 and in 
vitro27 occurs independently of GM-CSF, a known inducer of mo-
DC.117 “L-DC” do not express Stat3a, Stat5a or Stat5b which are 
important in GM-CSF-induced development of mo-DC (data not 
shown).117 “L-DC” development in vivo also occurs independently of 
BatF3, which is important in the development of DC as well as mo-
DC.118,119 Development of “L-DC” in vivo15 and in vitro27 was shown 
previously to occur in the absence of inducing cytokines like M-CSF, 
GM-CSF and Flt3L. Cell production also occurs in the absence of 
c‐Myb signalling, suggesting that development does not involve bone 
marrow-derived myeloid progenitors but may arise from progenitors 
endogenous to adult spleen.112 “L-DC” produced in vitro also mirrors 
an equivalent novel APC subset unique to spleen.
Gene expression profiles obtained here for resident monocytes 
compared with inflammatory monocytes are consistent with the 
literature on classical (inflammatory) and non-classical (resident) 
monocytes, where both monocyte subsets express Csf1r and Ccr2 
and encode receptors essential for monocyte development and mi-
gration.9,41 Resident monocytes did not show specific gene expres-
sion distinguishing them from inflammatory monocytes, although a 
number of distinct genes were upregulated by each subset. While 
resident monocytes required TLR signalling for their development, 
inflammatory (or classical) monocytes are a steady-state population 
in spleen, forming in the absence of inflammation. Similarity in gene 
profile can be attributed to their development from a common lin-
eage origin, or a common progenitor.48 Previously, it was reported 
that blood-derived Ly6Chi inflammatory (classical) monocytes were 
a precursor of Ly6Clo resident monocytes (non-classical and migra-
tory), although data obtained here would not support those findings 
for similar subsets in spleen.88
While the “L-DC” and resident monocyte populations are closely 
linked in terms of gene expression, the possibility that they have a 
precursor-progeny relationship is refuted on several counts. Firstly, 
it has always been impossible to drive “L-DC” to monocytes and vice 
versa through in vitro culture with factors like GM-CSF, Flt3L or 
through TLR activation with LPS (Ni, K. & Griffiths, K, unpublished 
data). In recent studies, however, it was shown that the development 
of resident monocytes but not “L-DC” was dependent on Flt3L and 
GM-CSF because knockout mice showed loss of resident monocytes 
but not “L-DC.”15 This suggests that the two cell types follow differ-
ent pathways for the development, although they may develop from 
a common progenitor. Data present here in mice which lack TLR-sig-
nalling molecules MyD88 and TRIFF, confirm that finding, showing a 
loss of resident monocytes but not of “L-DC.” In contrast, mice mu-
tant for c‐Myb show a loss of both resident monocytes and “L-DC,” 
consistent with the common progenitor origin.112 In vitro studies to 
define the hematopoietic progenitors which generated “L-DC” when 
cocultured above a splenic stromal line which supported hemato-
poiesis, revealed that “L-DC” arose only from HSC or multipotential 
progenitors and not from other myeloid progenitors,27 suggesting 
that “L-DC” may differentiate directly from HSC in the absence of 
formation of a myeloid progenitor. Our hypothesis therefore is that 
“L-DC” and resident monocytes may have a common progenitor ori-
gin in spleen but arise by divergent differentiation.
5  | CONCLUSION
The close relationship between gene profiles for “L-DC” and resi-
dent or non-classical monocytes raises questions about a possible 
common lineage origin. They are shown here to be quite distinct 
subsets in that resident monocytes require TLR signalling for their 
development, while “L-DC” do not. The latter could reflect a steady-
state population of APC in spleen developing in the absence of in-
flammatory signals. It is yet to be determined whether one of the 
resident monocyte or “L-DC” subsets is a precursor of the other, 
or whether they both reflect functionally distinct progeny of a 
common progenitor endogenous to spleen. This hypothesis would 
be consistent with the previous finding that both the “L-DC” and 
resident monocyte subsets develop independently of c‐Myb expres-
sion which distinguishes definitive haematopoiesis and is important 
for the development of myeloid progenitors in the bone marrow 
environment.112,120
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